Holen Sie sich die Stockscreener-App
6.38
0.93%
-0.06
Handel nachbörslich:
6.29
-0.09
-1.41%
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Press Releases about Mistras Group Inc Common Stock (NYSE:MG) - FinancialContent
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Na - StreetInsider
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq – WAFD) - Procurement Magazine
Halper Sadeh LLC is Investigating Whether MG, LFCR, MGLD are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capital Bancorp, Inc. (Nasdaq – CBNK), Lifecore Biomedical, Inc. (Nasdaq – LFCR), MISTRAS Group, Inc. (NYSE – MG), Utz Brands, Inc. (NYSE – UTZ) - Supply Chain Digital
Votes against certain rival proposals are part of Wynnefield's merger pledge at Lifecore Biomedical (LFCR). - Stock Titan
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifecore Biomedical, Inc. (NASDAQ: LFCR) - Morningstar
Lifecore Biomedical (Nasdaq: LFCR) Closes up on Acquisition News - Investorideas.com
Form 13D/A LIFECORE BIOMEDICAL For: 28 September By Investing.com - Investing.com Nigeria
Form 13D/A LIFECORE BIOMEDICAL For: 28 September By Investing.com - Investing.com India
Form 13D/A LIFECORE BIOMEDICAL For: 28 September By Investing.com - Investing.com Canada
A $6.28-a-share merger gets a voting pledge from Legion Partners at Lifecore Biomedical (LFCR). - Stock Titan
LFCR Stock Alert: Halper Sadeh LLC is Investigating Whether Lifecore Biomedical, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire
Form 8K Lifecore Biomedical Inc For: 28 September By Investing.com - Investing.com Nigeria
Form 8K Lifecore Biomedical Inc For: 28 September By Investing.com - Investing.com UK
Lifecore Biomedical to be acquired by Webster Equity Partners - TradingView
A 49.5% premium is built into Lifecore Biomedical’s (LFCR) proposed sale. The cash price is only part of the deal. - Stock Titan
Lifecore Biomedical to be Acquired by Webster Equity Partners - GlobeNewswire
Lifecore Biomedical: A Messy Balance Sheet, A Much Better Business (NASDAQ:LFCR) - Seeking Alpha
Lifecore plans customer meetings in Milan this October - Stock Titan
Lifecore Biomedical to Participate at CPHI Global Conference - Yahoo Finance
Lifecore Strikes Tech Transfer Deal for Commercial Manufacturing of Major Pharma Company Injectable - Contract Pharma
Lifecore Biomedical Signs New Commercial Transfer Agreement for Marketed Injectable Product - Quiver Quantitative
A marketed injectable drug is expected to bring Lifecore revenue in 2028. - Stock Titan
LFCR Q2 2026 Earnings: Narrower Loss of -$0.19 Beats Estimates, Shares Dip 1.35%Revenue Guidance Update - vinanet.vn
Lifecore (LFCR) Results at a Glance: EPS Lands Above Forecast in Latest Trading; Session Move: Shares Rise 0.22% at the CloseEarnings Season Preview - vinanet.vn
Lifecore (LFCR) Earnings Reading: EPS Prints Above Forecast at the Close; After Results: Shares Move 2.42% Down on the DayGuidance Downgrade Alert - vinanet.vn
LFCR | Lifecore Biomedical, Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
Lifecore Biomedical Earnings Call Balances Growth and Strain - TipRanks
Lifecore (LFCR) Quarterly Scorecard: EPS Beats Its Estimate; The Stock Records a 1.83% Increase on the DayROA Comparison - vinanet.vn
Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity - Yahoo Finance
Avoiding Lag: Real-Time Signals in (LFCR) Movement - Stock Traders Daily
Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript - AOL.com
LFCR Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 16.59% EPS SurpriseAnalyst Coverage Count - vinanet.vn
Lifecore Biomedical (LFCR) Holds Above $4.50 Support as Shares Edge LowerSell Signal Alerts - vinanet.vn
LFCR Q2 2026 Earnings: Narrower-than-Expected Loss Offers Modest EncouragementGuidance vs Actual - vinanet.vn
Lifecore Biomedical (LFCR) Holds Above $4.50 Support as Shares Edge LowerCash Secured Put - dars.gov.et
Judge approves $3.75 million Lifecore investor settlement - Minnesota Lawyer
Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript - The Globe and Mail
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - TMX Newsfile
Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update - marketscreener.com
Lifecore Biomedical, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Discipline and Rules-Based Execution in LFCR Response - Stock Traders Daily
Earnings call transcript: Lifecore Biomedical tops revenue view in Q2 2026 - Investing.com Canada
Lifecore Biomedical (NASDAQ:LFCR) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Earnings call transcript: Lifecore Biomedical tops revenue view in Q2 2026 - Investing.com
Transcript : Lifecore Biomedical, Inc., Q2 2026 Earnings Call, Aug 05, 2026 - marketscreener.com
Lifecore Biomedical, Inc. Reaffirms Earnings Guidance for the Calendar Year 2026 - marketscreener.com
LFCR: Revenue and profit declined, but cost cuts and new wins support strong long-term growth outlook - TradingView
Lifecore Biomedical, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
2.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):